Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging

Parkinsonism and Related Disorders

Volumn 19, Issue 6, 2013, Pages 622-627

  Wu, Ping ^a   Wang, Jian ^a   Peng, Shichun ^b   Ma, Yilong ^b   Zhang, Huiwei ^a   Guan, Yihui ^a   Zuo, Chuantao ^a  

^a FUDAN UNIVERSITY   (China)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

18F FDG; Parkinson's disease; Parkinson's disease related pattern; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN RADIOGRAPHY; CEREBELLUM; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NERVE CELL NETWORK; PARIETAL LOBE; PARKINSON DISEASE; PARKINSON DISEASE RELATED PATTERN; PONTINE NUCLEUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; RESTING STATE NETWORK; SENSITIVITY AND SPECIFICITY; THALAMUS NUCLEUS; VALIDATION STUDY; VOXEL BASED MORPHOMETRY; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; COHORT ANALYSIS; METABOLISM; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; ASIAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84891516113     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.02.013     Document Type: Article

References (30)

1. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
2. Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125:861-870.
3. Hughes A.J., Daniel S.E., Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001, 57:1497-1499.
4. Ravina B., Eidelberg D., Ahlskog J.E., Albin R.L., Brooks D.J., Carbon M., et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005, 64:208-215.
5. Vlaar A.M., de Nijs T., van Kroonenburgh M.J., Mess W.H., Winogrodzka A., Tromp S.C., et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol 2008, 8:42.
6. Seppi K., Scherfler C., Donnemiller E., Virgolini I., Schocke M.F., Goebel G., et al. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Arch Neurol 2006, 63:1154-1160.
7. Tatsch K. Positron emission tomography in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010, 7:330-340.
8. Attwell D., Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci 2002, 25:621-625.
9. Heeger D.J., Ress D. What does fMRI tell us about neuronal activity?. Nat Rev Neurosci 2002, 3:142-151.
10. Ma Y., Tang C., Spetsieris P.G., Dhawan V., Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007, 27:597-605.
11. Huang C., Tang C., Feigin A., Lesser M., Ma Y., Pourfar M., et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007, 130:1834-1846.
12. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 2009, 32:548-557.
13. Spetsieris P.G., Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage 2011, 54:2899-2914.
14. Eidelberg D., Moeller J.R., Dhawan V., Spetsieris P., Takikawa S., Ishikawa T., et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994, 14:783-801.
15. Eckert T., Tang C., Ma Y., Brown N., Lin T., Frucht S., et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008, 23:727-733.
16. Tang C.C., Poston K.L., Eckert T., Feigin A., Frucht S., Gudesblatt M., et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 2010, 9:149-158.
17. Wang J., Ma Y., Huang Z., Sun B., Guan Y., Zuo C. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol 2010, 257:72-78.
18. Hirano S., Asanuma K., Ma Y., Tang C., Feigin A., Dhawan V., et al. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 2008, 28:4201-4209.
19. Feigin A., Kaplitt M.G., Tang C., Lin T., Mattis P., Dhawan V., et al. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A 2007, 104:19559-19564.
20. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatr 1988, 51:745-752.
21. Mure H., Hirano S., Tang C.C., Isaias I.U., Antonini A., Ma Y., et al. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2011, 54:1244-1253.
22. Eidelberg D., Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Chaly T., et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med 1995, 36:378-383.
23. Lozza C., Baron J.C., Eidelberg D., Mentis M.J., Carbon M., Marie R.M. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 2004, 22:236-245.
24. Tang C.C., Eidelberg D. Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside. Prog Brain Res 2010, 184:161-176.
25. Wichmann T., Delong M.R. Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders. Handb Clin Neurol 2007, 83:1-18.
26. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007, 64:20-24.
27. Zaidel A., Arkadir D., Israel Z., Bergman H. Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol 2009, 22:387-393.
28. Volkmann J., Joliot M., Mogilner A., Ioannides A.A., Lado F., Fazzini E., et al. Central motor loop oscillations in parkinsonian resting tremor revealed by magnetoencephalography. Neurology 1996, 46:1359-1370.
29. Timmermann L., Gross J., Dirks M., Volkmann J., Freund H.J., Schnitzler A. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003, 126:199-212.
30. Aarsland D., Zaccai J., Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005, 20:1255-1263.